| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/06/2004 | EP1414485A1 Use of corticotroph-derived glycoprotein hormone to induce lipolysis |
| 05/06/2004 | EP1414484A1 Combination of selective cox-2 inhibitor and lung surfactant for respiratory syndrome |
| 05/06/2004 | EP1414483A1 Agonists and antagonists of moxifin for the treatment of metabolic disorders |
| 05/06/2004 | EP1414482A2 Medicament for locally treating or preventing a chemotherapy-induced mucositis and other side effects resulting from chemotherapy |
| 05/06/2004 | EP1414481A2 Use of lhrh-antagonists for the improvement of t-cell mediated immunity |
| 05/06/2004 | EP1414480A1 Osteogenic growth oligopeptides as stimulants of hematopoiesis |
| 05/06/2004 | EP1414479A1 Peptide for regulation of tissue plasminogen activator |
| 05/06/2004 | EP1414478A2 Inhibition of neurodegeneration |
| 05/06/2004 | EP1414477A2 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions |
| 05/06/2004 | EP1414474A1 High protein, bowman-birk inhibitor concentrate and process for its manufacture |
| 05/06/2004 | EP1414472A1 Method for preparing fetuin and polypeptide to induce apoptosis |
| 05/06/2004 | EP1414471A2 Therapeutic agents comprising pro-apoptotic proteins |
| 05/06/2004 | EP1414458A1 Oral administration of 6-hydroxy-oxymorphone for use as an analgesic |
| 05/06/2004 | EP1414445A1 Partial agonists at the glycine modulatory site of the nmda receptor for treating cognitive dysfunction |
| 05/06/2004 | EP1414441A2 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 05/06/2004 | EP1414439A1 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 05/06/2004 | EP1414432A2 Methods of use for novel sulfur containing organic nitrate compounds |
| 05/06/2004 | EP1414421A1 The treatment of lipodystrophy |
| 05/06/2004 | EP1414420A1 Method for the continuous production and coating of self-adhesive compounds on the basis of sbc that includes at least one pharmaceutically active substance |
| 05/06/2004 | EP1414411A1 Pulmonary formulation comprising silicon particles |
| 05/06/2004 | EP1414406A2 A bioactive agent delivering system comprised of microparticules within a biodegradable to improve release profiles |
| 05/06/2004 | EP1414370A1 Dry hemostatic compositions and methods for their preparation |
| 05/06/2004 | EP1414316A1 Nutritional composition preventing bacterial overgrowth |
| 05/06/2004 | EP1206489B1 Orally active peptides that prevent cell damage and death |
| 05/06/2004 | EP1181027B1 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 05/06/2004 | EP1165138B1 Programmed controlled ovarian stimulation protocol using oral contraceptives |
| 05/06/2004 | EP1117645B1 Aryl-substituted propanolamine derivatives, methods for their production, medicaments containing said compounds and their use |
| 05/06/2004 | EP1088088A4 Diacylglycerol o-acyltransferase |
| 05/06/2004 | EP0980203A4 Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases |
| 05/06/2004 | EP0889955B1 Recombinant phages |
| 05/06/2004 | EP0871466B1 Linear and cyclic peptides for the treatment or prevention of eczema/dermatitis |
| 05/06/2004 | EP0868197B1 Anti-l-selectin antibodies for prevention of multiple organ failure and acute organ damage |
| 05/06/2004 | EP0821696B1 Peptide antagonists of cellular mitogenesis and motogenesis and their therapeutic use |
| 05/06/2004 | EP0812209B1 Cochleate delivery vehicles for biologically relevant molecules |
| 05/06/2004 | EP0792287B1 Peptide analogs of human myelin basic protein |
| 05/06/2004 | EP0776161B1 Use of a viral vector encoding a cytochrome p450 gene in combination with a chemotherapeutic agent for selectively destroying neoplastic cells |
| 05/06/2004 | DE10305082A1 MIA-2 Protein MIA-2 protein |
| 05/06/2004 | DE10248751A1 Dyslokalisationsmoleküle und deren Verwendung Dyslokalisationsmoleküle and their use |
| 05/06/2004 | CA2505597A1 Agent elevating dendritic cell precursor level in blood |
| 05/06/2004 | CA2503305A1 Methods for treating viral infection using il-28 and il-29 |
| 05/06/2004 | CA2503164A1 Gpr54 knock-out mammals and screening methods using them |
| 05/06/2004 | CA2502960A1 Active specific immunotherapy of cancer metastasis |
| 05/06/2004 | CA2502663A1 Methods to prevent tumor recurrence by blockade of tgf-.beta. |
| 05/06/2004 | CA2502600A1 Methods of treating dry eye disease with lantibiotics |
| 05/06/2004 | CA2502453A1 Angiogenesis inducer |
| 05/06/2004 | CA2502118A1 Glp-1 derivatives and transmicosal absorption preparations thereof |
| 05/06/2004 | CA2501677A1 Treatment of diabetes |
| 05/06/2004 | CA2499459A1 Polymerized hemoglobin solution for treating patients with massive blood loss |
| 05/06/2004 | CA2497909A1 Low dose methods for treating disorders in which tnf.alpha. activity is detrimental |
| 05/06/2004 | CA2468903A1 Endogenous retrovirus up-regulated in prostate cancer |
| 05/05/2004 | CN1494593A Modified ciliary neurotrophic factor (CNTF) with reduced immunogenicity |
| 05/05/2004 | CN1494592A Nucleic acid expressed in hypothalamus or muscle tissue in obese animals |
| 05/05/2004 | CN1494591A Polynucleotide useful for modulating cancer cell proliferation |
| 05/05/2004 | CN1494590A Modified thrombopoietin with reduced immunogenicity |
| 05/05/2004 | CN1494588A Use of protein histidine phosphatase |
| 05/05/2004 | CN1494552A Flt 4 (VEGFR-3) as target for tumor imaging and anti-tumor therapy |
| 05/05/2004 | CN1494551A Modified granulocyte macrophage colony stimulating factor (GM-CSF) with reduced immunogenicity |
| 05/05/2004 | CN1494433A Use of CD 23 antagonists for treatment of neoplastic disorders |
| 05/05/2004 | CN1494431A Stable enzymatic wound debrider |
| 05/05/2004 | CN1494430A Modified protamine with reduced immunogenicity |
| 05/05/2004 | CN1494420A Compounds and compositions for delivering active agents |
| 05/05/2004 | CN1148577C Antibodies and SCFV immunotoxins specific to improted fire ants, and their application |
| 05/05/2004 | CN1148449C Mutants of streptococcal toxin C and methods of use |
| 05/05/2004 | CN1148447C Amino-terminally trancated RANTES as chemokine antagonists |
| 05/05/2004 | CN1148446C Polypeptide bound with MORT-1 and MACH and its DNA sequence, producing method, medical composition and use |
| 05/05/2004 | CN1148381C New human chemotaxis factor macrophage inflammatory protein, its coding sequence and use |
| 05/05/2004 | CN1148379C Antibiotic/antiendotoxic mimic peptide and its preparation and application |
| 05/05/2004 | CN1148228C Gene medicine for treating hemophilia B and its preparing process |
| 05/05/2004 | CN1148224C Cyclosporin containing composition and process for preparation |
| 05/05/2004 | CN1148223C Enopeptin containing compound preparation and its medical use for controlling sutaneous pigmentation |
| 05/05/2004 | CN1148168C Micronised pharmaceutical compositions |
| 05/04/2004 | US6730779 Antibody that specifically binds an Mch4 polypeptide |
| 05/04/2004 | US6730776 An antimicrobial compound produced by culturing and deacylating in the presence a microbial substance; used for treatment of infectious diseases caused by pathogenic microorganisms such as yeast or fungi |
| 05/04/2004 | US6730775 Methods for limiting scar and adhesion formation |
| 05/04/2004 | US6730698 Method and compositions for administering taxanes orally to human patients |
| 05/04/2004 | US6730696 Phospholipid derivatives of non-steroidal anti-inflammatory drugs |
| 05/04/2004 | US6730692 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| 05/04/2004 | US6730686 Methods for inhibiting oxidative modification of proteins |
| 05/04/2004 | US6730669 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 05/04/2004 | US6730662 For use in treating conditions which involve inappropriate cell survival, such as cancer |
| 05/04/2004 | US6730660 Peritoneal dialysis solutions with polypeptides |
| 05/04/2004 | US6730659 Antimicrobial peptides and methods of use thereof |
| 05/04/2004 | US6730658 Stimulation of lymphatic growth with an FLT4 ligand |
| 05/04/2004 | US6730657 Combination of structural domains derived from the alpha subunits of hepatocyte growth factor and macrophage stimulating protein to treat chemotherapeutically induced toxicity |
| 05/04/2004 | US6730511 Vectors that repress heterologous promoter activity |
| 05/04/2004 | US6730506 Isolated human kinase proteins |
| 05/04/2004 | US6730505 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 05/04/2004 | US6730498 Production of functional proteins: balance of shear stress and gravity |
| 05/04/2004 | US6730491 Nucleotide sequences coding an enzymatic polypeptide for use in the treatment of cell proliferative or differentiative, nervous system, immune, cardiovascular, liver and skin disorders |
| 05/04/2004 | US6730486 Human βTrCP protein |
| 05/04/2004 | US6730480 Sphingosine kinase enzyme |
| 05/04/2004 | US6730334 Multi-arm block copolymers as drug delivery vehicles |
| 05/04/2004 | US6730328 Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity |
| 05/04/2004 | US6730324 Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| 05/04/2004 | US6730323 Aqueous solution containing carbomer, propylene glycol, glycerin, dmdm hydantoin, citric acid, chondroitin sulfate, animal protein and triethanolamine |
| 05/04/2004 | US6730307 Monoclonal antibody |
| 05/04/2004 | US6730305 Nucleotide sequences encoding bovine respiratory syncytial virus immunogenic proteins |
| 05/04/2004 | US6730304 Viral nuceotide sequences for use in the diagnosis of viral diseases |
| 05/04/2004 | US6730303 Fused G-CSF and IL-3 proteins and uses thereof |
| 05/04/2004 | US6730301 Mediating chemotaxis and activation of monocytes; athero-sclerosis; monocyte chemoattractant protein-1 (mcp-1) |